Anxiety Disorders Unknown Status Phase 3 Trials for Cyproterone acetate (DB04839)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00632983Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate CancerTreatment